ESC Premium Access

ETNA-AF Europe: First 1-year follow-up snapshot analysis of more than 7,500 AF patients treated with edoxaban in routine clinical practice

Presentation

About the speaker

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
25 presentations
1 follower

5 more presentations in this session

Stroke severity and subsequent mortality are worse with atrial fibrillation than in patients without atrial fibrillation

Speaker: Ms N. Vinding (Copenhagen, DK)

Thumbnail

Comparative safety and effectiveness of standard doses of apixaban versus dabigatran, rivaroxaban, and VKAs in non-valvular atrial fibrillation patients in France: the NAXOS study

Speaker: Professor N. Danchin (Paris, FR)

Thumbnail

Resumption of anticoagulant treatment in patients with atrial fibrillation following gastrointestinal bleeding: a nationwide cohort study

Speaker: Miss D. Rajan (Copenhagen, DK)

Thumbnail

Left atrial dimension and risk of cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis

Speaker: Doctor P. Meyre (Basel, CH)

Thumbnail

Right atrial low voltage zone as a novel predictor of sinus node dysfunction in patients with non-paroxysmal atrial fibrillation

Speaker: Doctor T. Kondo (Hiroshima, JP)

Thumbnail

Access the full session

Identifying and managing complications of atrial fibrillation

Speakers: Professor R. De Caterina, Ms N. Vinding, Professor N. Danchin, Miss D. Rajan, Doctor P. Meyre...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk